FMP
Zoetis Inc.
ZTS
NYSE
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
157.44 USD
1.79 (1.14%)
2024
2023
2022
2021
9.26B
8.54B
8.08B
7.78B
2.72B
2.71B
2.45B
2.3B
6.54B
5.83B
5.63B
5.47B
3.15B
2.77B
2.7B
2.67B
686M
614M
539M
508M
2.32B
2.15B
2.01B
2B
0
281M
287M
292M
0
1.87B
1.72B
1.71B
141M
0
150M
161M
3.39B
3.07B
2.89B
2.75B
-259M
-133M
-430M
-484M
3.13B
2.94B
2.66B
2.49B
637M
596M
545M
454M
2.49B
2.34B
2.11B
2.04B
5.47
5.08
4.51
4.29
5.47
5.07
4.49
4.27
454.2M
461.17M
468.89M
474.35M
454.85M
462.27M
470.38M
476.72M
3.87B
3.69B
3.36B
3.17B
2024
2023
2022
2021
10.29B
8.67B
7.19B
5.66B
2.49B
2.34B
2.11B
2.04B
-1.86B
-1.09B
-1.59B
-743M
-786M
-692M
-611M
-474M
11.97B
10.29B
8.67B
7.19B
-971M
-157M
-723M
310M
2024
2023
2022
2021
3.61B
3.43B
2.97B
2.6B
497M
491M
465M
448M
-655M
-732M
-586M
-477M
3.77B
3.67B
3.09B
2.63B
2024
2023
2022
2021
-35M
13M
64M
-12M
2.76B
2.75B
2.68B
2.69B
2.72B
2.76B
2.75B
2.68B
All figures are in USD.